A Gram-negative, obligate anaerobic genus within the Firmicutes phylum (class Negativicutes, family Veillonellaceae). The primary species V. parvula is a specialized lactate utilizer that occupies a unique metabolic niche by cross-feeding with lactate-producing bacteria, particularly streptococcus. Veillonella is abundant in both the oral cavity and gut, making it a central player in the oral-gut translocation story that connects oral dysbiosis to systemic disease.
Role in Gut Ecosystem
- Cannot ferment sugars or complex carbohydrates directly; instead specializes in lactate utilization, converting lactate into propionate, acetate, CO2, and H2 via the methylmalonyl-CoA pathway.
- Forms a tightly coupled cross-feeding partnership with Streptococcus: Streptococcus produces lactate from sugar fermentation, and Veillonella consumes it, preventing lactate accumulation that would acidify the environment and inhibit both organisms.
- This partnership operates in both the oral cavity (dental plaque) and the gut, representing one of the best-characterized syntrophic relationships in the human microbiome.
- H2 production from lactate fermentation feeds hydrogenotrophic organisms including methanobrevibacter and sulfate-reducing bacteria.
Oral-Gut Translocation
- Veillonella is one of the most abundant genera in the oral microbiome, particularly in dental plaque and the tongue dorsum.
- Oral Veillonella can survive gastric transit and colonize the gut, contributing to the oral-gut axis increasingly recognized in autoimmune and inflammatory disease.
- Oral-to-gut translocation of Veillonella is enhanced by conditions that reduce gastric acid barrier function (PPI use, achlorhydria) or increase gut permeability.
Disease Associations
Multiple Sclerosis
- Enriched in MS patients in multiple studies. Found exclusively in the MS patient group (absent in controls) in the oral microbiome study by Zangeneh 2021 [1].
- Elevated in both oral and gut compartments of MS patients, consistent with increased oral-gut translocation under inflammatory conditions.
- Part of the Negativicutes expansion seen in MS alongside other propionate-producing genera.
Graves' Disease
- Enriched in graves disease patients, alongside Prevotella and Megasphaera, contributing to the pro-inflammatory gut signature that characterizes thyroid autoimmunity [2].
Autism Spectrum Disorder
- Decreased in ASD youth in the Romano 2023 umbrella review, contrasting with its enrichment in autoimmune conditions [3].
Key Metabolites
- Propionate — primary product from lactate fermentation; immunomodulatory SCFA
- Acetate — secondary product
- H2 — feeds hydrogenotrophic methanogens and sulfate reducers
- CO2 — byproduct of lactate metabolism
Mechanistic Considerations
- The enrichment of Veillonella in autoimmune disease may reflect increased oral-gut translocation rather than gut-specific expansion. Compromised gut barrier function in MS and Graves' disease allows oral bacteria to establish colonic populations.
- Lactate utilization could be beneficial (preventing lactate accumulation) or detrimental (removing substrate from beneficial lactate-utilizing butyrate producers like Anaerostipes).
- The H2 produced by Veillonella could support the expansion of methanobrevibacter, which is also elevated in MS, suggesting a metabolic cascade.
Key Sources
Connections
- multiple sclerosis — enriched in MS oral and gut microbiome; oral-gut translocation marker
- graves disease — enriched in GD; part of pro-inflammatory gut signature
- methanobrevibacter — H2 cross-feeding; both elevated in MS
- dorea — both enriched in MS; potential metabolic network via H2 production
- short chain fatty acids — propionate and acetate producer from lactate
- autism spectrum disorder — decreased in ASD (opposite to autoimmune pattern)
- porphyromonas — co-member of oral-gut translocation consortium
- inflammation — enrichment in autoimmune disease suggests pro-inflammatory context
- dysbiosis — oral-gut translocation as a mechanism of gut dysbiosis